Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

CRSP reports encouraging fourth-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is ...

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the appointment ...

Google’s 2.0 Flash model is now widely accessible via the Gemini API in Google AI Studio and Vertex AI. This powerful, high-performance model is optimised for low-latency operations, making it ...

What are the Magnificent Seven stocks? How much market cap weighting do AAPL, MSFT, GOOGL, AMZN, META, TSLA and NVDA have on ...

Dividend stocks can be terrific investments. The best ones provide investors with passive income and upside potential. Over ...

We recently compiled a list of the Top 10 Must-See AI News Updates for Investors. In this article, we are going to take a look at where Alpha Modus Holdings, Inc. (NASDAQ:AMOD) stands against the ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

The models are now available on the Gemini app, Google AI Studio, and Vertex AI platforms. The Clash of Clans Lunar New Year Medal Event runs from February 7 to 27, 2025, featuring snake-themed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...